List Labs Bacterial Toxin & Vaccine Research Blog

Vaccine Development for the Control of Bordetella Pertussis Infections (Whooping Cough)

April 6, 2015

By: List Labs

By: Suzanne Canada, Ph.D. Tanager Medical Writing Concerns over outbreaks of potentially serious childhood diseases are in the news again in California with an increase in whooping cough infections in 2014, caused by the pathogen Bordetella pertussis, and a measles outbreak in December 2014 to February 2015. Since outbreaks and epidemics may be infrequent, many […]

Read more

List Products for Microbiome Research and Discovery

March 16, 2015

By: List Labs

By: Suzanne Canada, Ph.D. Tanager Medical Writing While you go about your day, you are surrounded by micro-organisms. Although most of us spend a lot of time washing up and trying not to think about the propensity of creatures that share our personal space, scientists have been studying them. Due to their great progress, we […]

Read more

New cholera toxin for stimulating cells

March 9, 2015

By: douano@listlabs.com

Original Post By: Linda Eaton, Ph.D., VP of Research and Development Eva Purro, Director of Quality Assurance Updates by: Dom C. Ouano, Marketing 4-13-15 Cholera QD Product #9100B is now available for purchase online. Vial Size: 1 mg List Price: $550/vial Minimum order: 5 vials 4-8-15 Cholera QD Product #9100B is now available from stock. Vial Size: […]

Read more

Toxins in the news: Stem cells that deliver cytotoxins to cancer tumors

January 26, 2015

By: List Labs

By: Suzanne Canada, Ph.D. Tanager Medical Writing An exciting report was released in October about a new class of targeted anti-tumor drugs, in which genetically engineered stem cells were used to deliver cytotoxins to brain tumors.1 Brain cancers known as glioblastomas (GBM) are notoriously difficult to treat because the tumors often re-grow after surgery and because […]

Read more

Interview with Fundastic

January 12, 2015

By: List Labs

Fundastic believes in being objective and transparent when it comes to funding and financing for small businesses. The following is an interview between Fundastic writer Sarah Tang and List Labs President Dr. Karen Crawford. View the original post here. By: Sarah Tang Fundastic Business Owner Stories Dr. Karen Crawford is the president of List Labs, a manufacturing […]

Read more

Anthrax toxin research takes several directions in 2014

January 5, 2015

By: List Labs

By: Suzanne Canada, Ph.D. Tanager Medical Writing Three anthrax toxin components—Protective antigen (PA), edema factor (EF) and lethal factor (LF) are available for research purposes from LIST Biological Laboratories, separately at a high level of purification. At least two out of three of these components are necessary to enter a mammalian cell and exert […]

Read more